Qiagen cuts jobs
Hilden/Venlo – Sample and assay technologies provider Qiagen N.V. is set to eliminate about 10% of its current global workforce of 3,800 employees. The company says the cuts are one result of implementing a project aimed at further improving its strong competitive positions in the molecular diagnostics and life sciences markets. Qiagen is in the midst of a general revamp as it attempts to eliminate organisational layers and redundant structures, and also free up and optimise resources. The company said it plans to implement the actions by the end of 2012, and predicts they will generate annual pre-tax cost savings of about US$50m. It says it will re-invest a major chunk of the savings in more profitable areas.